INAUGURAL POST

Nonpartisan pharma news and views from the horse’s mouth, not the jockey’s

A Short Journey Back to the Future

I thought to reproduce this inaugural post from Inside Pharma, dated January 21st 2022. At the time, there were 123 subscribers (if you are one of them, please make yourself known :O)):

“WE NEED TO KNOW THIS WILL GET PROPER REGULATORY SCRUTINY

Hot on the heels of the Pfizer/BioNTech SARS-CoV-2 injection comes the next can…